RAS and EF Hand Domain Containing (RASEF) (N-Term) Peptide
RASEF
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all RASEF products
- RASEF (RAS and EF Hand Domain Containing (RASEF))
- Protein Region
- N-Term
- Origin
- Human
- Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- AQDKAAMQLS ELEEEMDQRI QAAEHKTRKD EKRKAEEALS DLRRQYETEV
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-RASEF Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- RASEF (RAS and EF Hand Domain Containing (RASEF))
- Synonyms
- BC030882 Peptide, RAB45 Peptide, si:ch73-275j21.1 Peptide, RAS and EF hand domain containing Peptide, RAS and EF-hand domain containing Peptide, Rasef Peptide, RASEF Peptide, rasef Peptide
- Background
-
RASEF binds predominantly GDP, and also GTP.
Alias Symbols: FLJ31614, RAB45
Protein Size: 740 - Molecular Weight
- 81 kDa
- Gene ID
- 158158
- NCBI Accession
- NM_152573, NP_689786
- UniProt
- Q8IZ41
-
You are here:
